Cannabis Sativa, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
November 20, 2023 at 03:08 pm EST
Share
Cannabis Sativa, Inc. reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported sales was USD 0.271207 million compared to USD 0.383079 million a year ago. Net loss was USD 0.227748 million compared to USD 0.067558 million a year ago.
For the nine months, sales was USD 0.939772 million compared to USD 1.26 million a year ago. Net loss was USD 1.08 million compared to USD 0.509014 million a year ago. Basic loss per share from continuing operations was USD 0.02 compared to USD 0.01 a year ago.
Cannabis Sativa, Inc. is engaged in telehealth through its 51% owned subsidiary and the licensing of cannabis-related intellectual property (IP), marketing and branding for cannabis-based products and services, operation of cannabis-related technology services, and ancillary business activities. It operates through various subsidiaries, including PrestoCorp, Inc. (PrestoCorp), Wild Earth Naturals, Inc., Kubby Patent and Licenses Limited Liability Company, Hi Brands, International, Inc., Eden Holdings LLC, and iBudtender, Inc., GK Manufacturing and Packaging, Inc. PrestoCorp offers an online telemedicine platform providing customer access to knowledgeable physicians to obtain a medical marijuana recommendation. PrestoCorp uses video conferencing technology to provide a safe and confidential forum for the doctor patient interview in accordance with state regulations governing issuance of medical marijuana cards. It offers services in California, Nevada, New York, Missouri, and Oklahoma.
CANNABIS SATIVA, INC. 
